)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Maravai LifeSciences
Maravai LifeSciences (MRVI) investor relations material
Maravai LifeSciences Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary25 Feb, 2026
Executive summary
Full-year 2025 revenue was $185.7 million, with Q4 revenue of $49.9 million and a return to positive adjusted EBITDA of $0.5 million after several loss quarters.
Cost savings exceeded $65 million annualized, well above the initial $50 million target, supporting margin expansion and profitability.
TriLink and Cygnus segments were renamed for brand alignment, with TriLink driving growth in GMP consumables and CDMO, and Cygnus growth led by core customers.
Organizational restructuring and cost reduction initiatives were completed ahead of schedule, positioning for operational excellence and improved profitability.
Financial highlights
Q4 revenue: $49.9 million, with 18% year-over-year growth excluding $14.3 million COVID CleanCap comp; full-year revenue: $185.7 million.
Q4 GAAP net loss: $63 million (includes $25.8 million intangible asset impairment and $12.1 million restructuring charges); full-year GAAP net loss: $230.8 million.
Adjusted EBITDA Q4: $0.5 million (vs. -$1.1 million Q4 2024); full-year adjusted EBITDA: -$31.2 million.
Ended year with $216.9 million cash, $294.2 million long-term debt; net cash of $(77.3) million.
Q4 adjusted EPS loss: $0.04; full-year adjusted EPS loss: $0.29.
Outlook and guidance
2026 revenue expected at $200–$210 million (8–13% growth); TriLink to grow low double digits, Cygnus low to mid single digits.
Full-year adjusted EBITDA guidance: $18–$20 million, a $50–$52 million improvement over 2025.
Gross margin expansion of ~1,200 basis points expected, driven by cost actions and product mix.
Operating expenses to decline ~13%; G&A down 18%, sales/marketing down 13%, R&D modestly up.
Net capital expenditures for 2026 expected at $4–$6 million.
How sustainable are the cost savings for future margins?
ModTail's role in TriLink's 2026 growth drivers
Cygnus growth drivers beyond HCP kits
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Next Maravai LifeSciences earnings date
Q1 202611 May, 2026
Maravai LifeSciences
Next Maravai LifeSciences earnings date
Q1 202611 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Maravai LifeSciences Holdings, Inc. is a life sciences company providing products for research and development of drug therapies to enable the discovery, development, manufacture and commercialization of novel vaccines, therapeutics and diagnostic tests. The company's main offerings includes innovative and cost-effective products, technologies and services to the biopharmaceutical, vaccine and other healthcare industries. From small molecule development through to cell culture process development, Maravai offers a wide range of enzyme-linked immunoassay (ELISA) reagents for diagnostics development, safety testing and commercial production. Maravai's customers include market-leading companies - to which they sell proprietary technologies that enables rapid development of drug therapies, including antibody-based therapeutics, globally. Maravai LifeSciences Holdings, Inc. was founded in 2014 and is headquartered in San Diego, California.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage